

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 6.19507968 |
| 2 | doxorubicin metabolic process (GO:0044598) | 6.19507968 |
| 3 | daunorubicin metabolic process (GO:0044597) | 6.19507968 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.93951490 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.93951490 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 5.74799732 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.72544537 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.72544537 |
| 9 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.68457675 |
| 10 | cellular modified amino acid catabolic process (GO:0042219) | 5.42041250 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 5.32686984 |
| 12 | coenzyme catabolic process (GO:0009109) | 5.30407979 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.28073166 |
| 14 | NADH metabolic process (GO:0006734) | 5.01594773 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.96490093 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.96490093 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.96490093 |
| 18 | cysteine metabolic process (GO:0006534) | 4.90331362 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.79119261 |
| 20 | lysine catabolic process (GO:0006554) | 4.76655119 |
| 21 | lysine metabolic process (GO:0006553) | 4.76655119 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 4.72748309 |
| 23 | tryptophan metabolic process (GO:0006568) | 4.63701584 |
| 24 | tricarboxylic acid metabolic process (GO:0072350) | 4.52224209 |
| 25 | triglyceride catabolic process (GO:0019433) | 4.39484767 |
| 26 | glycine metabolic process (GO:0006544) | 4.37692294 |
| 27 | bile acid biosynthetic process (GO:0006699) | 4.34233595 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.24654793 |
| 29 | serine family amino acid metabolic process (GO:0009069) | 4.21408476 |
| 30 | low-density lipoprotein particle clearance (GO:0034383) | 4.19755974 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 4.17957881 |
| 32 | serine family amino acid biosynthetic process (GO:0009070) | 4.17788924 |
| 33 | UV protection (GO:0009650) | 4.11208295 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.06625619 |
| 35 | acylglycerol catabolic process (GO:0046464) | 4.03671026 |
| 36 | neutral lipid catabolic process (GO:0046461) | 4.03671026 |
| 37 | urea metabolic process (GO:0019627) | 3.99854402 |
| 38 | urea cycle (GO:0000050) | 3.99854402 |
| 39 | valine metabolic process (GO:0006573) | 3.98274324 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 3.96976131 |
| 41 | drug metabolic process (GO:0017144) | 3.96529692 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 3.95679114 |
| 43 | cellular amino acid catabolic process (GO:0009063) | 3.95395338 |
| 44 | proline biosynthetic process (GO:0006561) | 3.95276846 |
| 45 | homocysteine metabolic process (GO:0050667) | 3.94320369 |
| 46 | alpha-linolenic acid metabolic process (GO:0036109) | 3.93937463 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 3.92949090 |
| 48 | primary alcohol catabolic process (GO:0034310) | 3.92787650 |
| 49 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.91885478 |
| 50 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.91885478 |
| 51 | heme transport (GO:0015886) | 3.90421867 |
| 52 | hormone catabolic process (GO:0042447) | 3.87890389 |
| 53 | urate metabolic process (GO:0046415) | 3.86457493 |
| 54 | negative regulation of fibrinolysis (GO:0051918) | 3.84063448 |
| 55 | drug transmembrane transport (GO:0006855) | 3.83855483 |
| 56 | cofactor catabolic process (GO:0051187) | 3.83769287 |
| 57 | oxaloacetate metabolic process (GO:0006107) | 3.80815982 |
| 58 | diacylglycerol metabolic process (GO:0046339) | 3.79593752 |
| 59 | protein retention in ER lumen (GO:0006621) | 3.75145460 |
| 60 | nitrogen cycle metabolic process (GO:0071941) | 3.67611815 |
| 61 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.66374200 |
| 62 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.65139794 |
| 63 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.64531291 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 3.64394239 |
| 65 | flavonoid metabolic process (GO:0009812) | 3.59549529 |
| 66 | bile acid metabolic process (GO:0008206) | 3.57463438 |
| 67 | branched-chain amino acid catabolic process (GO:0009083) | 3.56227504 |
| 68 | ethanol oxidation (GO:0006069) | 3.56072337 |
| 69 | drug catabolic process (GO:0042737) | 3.55054846 |
| 70 | COPI coating of Golgi vesicle (GO:0048205) | 3.52307142 |
| 71 | Golgi transport vesicle coating (GO:0048200) | 3.52307142 |
| 72 | regulation of fibrinolysis (GO:0051917) | 3.51707819 |
| 73 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.50927908 |
| 74 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.47174747 |
| 75 | biotin metabolic process (GO:0006768) | 3.45813859 |
| 76 | negative regulation of sterol transport (GO:0032372) | 3.44711592 |
| 77 | negative regulation of cholesterol transport (GO:0032375) | 3.44711592 |
| 78 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.44549421 |
| 79 | imidazole-containing compound metabolic process (GO:0052803) | 3.43867123 |
| 80 | drug transport (GO:0015893) | 3.41679981 |
| 81 | branched-chain amino acid metabolic process (GO:0009081) | 3.39788684 |
| 82 | pentose-phosphate shunt (GO:0006098) | 3.39644378 |
| 83 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.38134326 |
| 84 | protein carboxylation (GO:0018214) | 3.36084821 |
| 85 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.36084821 |
| 86 | glucose catabolic process (GO:0006007) | 3.35725181 |
| 87 | benzene-containing compound metabolic process (GO:0042537) | 3.35595465 |
| 88 | indolalkylamine metabolic process (GO:0006586) | 3.35573028 |
| 89 | organic acid catabolic process (GO:0016054) | 3.35449102 |
| 90 | carboxylic acid catabolic process (GO:0046395) | 3.35449102 |
| 91 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.32848619 |
| 92 | regulation of protein activation cascade (GO:2000257) | 3.32511718 |
| 93 | negative regulation of epidermis development (GO:0045683) | 3.31477845 |
| 94 | fatty acid catabolic process (GO:0009062) | 3.28031973 |
| 95 | aspartate family amino acid catabolic process (GO:0009068) | 3.27765616 |
| 96 | proline metabolic process (GO:0006560) | 3.27335866 |
| 97 | protein maturation by protein folding (GO:0022417) | 3.25382461 |
| 98 | negative regulation of cell size (GO:0045792) | 3.24742478 |
| 99 | short-chain fatty acid metabolic process (GO:0046459) | 3.24462403 |
| 100 | cellular ketone body metabolic process (GO:0046950) | 3.24056919 |
| 101 | GDP-mannose metabolic process (GO:0019673) | 3.23362633 |
| 102 | xenobiotic catabolic process (GO:0042178) | 3.22779509 |
| 103 | iron-sulfur cluster assembly (GO:0016226) | 3.22664960 |
| 104 | metallo-sulfur cluster assembly (GO:0031163) | 3.22664960 |
| 105 | regulation of cholesterol esterification (GO:0010872) | 3.21619689 |
| 106 | regulation of triglyceride catabolic process (GO:0010896) | 3.20411435 |
| 107 | amine catabolic process (GO:0009310) | 3.20159675 |
| 108 | cellular biogenic amine catabolic process (GO:0042402) | 3.20159675 |
| 109 | tyrosine metabolic process (GO:0006570) | 3.19477308 |
| 110 | complement activation, alternative pathway (GO:0006957) | 3.19413380 |
| 111 | 2-oxoglutarate metabolic process (GO:0006103) | 3.18750107 |
| 112 | exogenous drug catabolic process (GO:0042738) | 3.17678611 |
| 113 | negative regulation of granulocyte differentiation (GO:0030853) | 3.17135704 |
| 114 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.16118976 |
| 115 | organic cation transport (GO:0015695) | 3.15644180 |
| 116 | cellular glucuronidation (GO:0052695) | 3.14405923 |
| 117 | glutamate metabolic process (GO:0006536) | 3.13590782 |
| 118 | triglyceride homeostasis (GO:0070328) | 3.12333869 |
| 119 | acylglycerol homeostasis (GO:0055090) | 3.12333869 |
| 120 | L-serine metabolic process (GO:0006563) | 3.11947255 |
| 121 | ethanol metabolic process (GO:0006067) | 3.11746975 |
| 122 | sulfur amino acid metabolic process (GO:0000096) | 3.11553742 |
| 123 | acetyl-CoA metabolic process (GO:0006084) | 3.09388778 |
| 124 | creatine metabolic process (GO:0006600) | 3.09260376 |
| 125 | regulation of complement activation (GO:0030449) | 3.08627300 |
| 126 | aldehyde catabolic process (GO:0046185) | 3.08109769 |
| 127 | fatty acid beta-oxidation (GO:0006635) | 3.06655578 |
| 128 | carnitine metabolic process (GO:0009437) | 3.06546193 |
| 129 | cofactor transport (GO:0051181) | 3.05417522 |
| 130 | reverse cholesterol transport (GO:0043691) | 3.04110590 |
| 131 | folic acid metabolic process (GO:0046655) | 3.02986077 |
| 132 | NADPH regeneration (GO:0006740) | 3.01210140 |
| 133 | response to mercury ion (GO:0046689) | 3.00983241 |
| 134 | plasma lipoprotein particle remodeling (GO:0034369) | 3.00947969 |
| 135 | protein-lipid complex remodeling (GO:0034368) | 3.00947969 |
| 136 | macromolecular complex remodeling (GO:0034367) | 3.00947969 |
| 137 | regulation of cholesterol metabolic process (GO:0090181) | 2.99087372 |
| 138 | monocarboxylic acid catabolic process (GO:0072329) | 2.91880352 |
| 139 | barbed-end actin filament capping (GO:0051016) | 2.91004323 |
| 140 | fatty acid homeostasis (GO:0055089) | 2.90637527 |
| 141 | arginine catabolic process (GO:0006527) | 2.90449836 |
| 142 | fatty acid oxidation (GO:0019395) | 2.90334047 |
| 143 | regulation of cholesterol storage (GO:0010885) | 2.89574631 |
| 144 | base-excision repair, AP site formation (GO:0006285) | 2.85811366 |
| 145 | glycerolipid catabolic process (GO:0046503) | 2.82414570 |
| 146 | lipid oxidation (GO:0034440) | 2.81820737 |
| 147 | 4-hydroxyproline metabolic process (GO:0019471) | 2.79168526 |
| 148 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.78978439 |
| 149 | negative regulation of B cell apoptotic process (GO:0002903) | 2.77730052 |
| 150 | gluconeogenesis (GO:0006094) | 2.73444456 |
| 151 | monosaccharide biosynthetic process (GO:0046364) | 2.71186103 |
| 152 | heme biosynthetic process (GO:0006783) | 2.69279606 |
| 153 | response to misfolded protein (GO:0051788) | 2.68679755 |
| 154 | deoxyribonucleotide catabolic process (GO:0009264) | 2.67285753 |
| 155 | peptidyl-arginine methylation (GO:0018216) | 2.65179512 |
| 156 | peptidyl-arginine N-methylation (GO:0035246) | 2.65179512 |
| 157 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.64363244 |
| 158 | autophagic vacuole fusion (GO:0000046) | 2.64149934 |
| 159 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.63344354 |
| 160 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.60627264 |
| 161 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.60153524 |
| 162 | regulation of sequestering of triglyceride (GO:0010889) | 2.59399842 |
| 163 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.54524346 |
| 164 | heme metabolic process (GO:0042168) | 2.53591449 |
| 165 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.53276138 |
| 166 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.53101010 |
| 167 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.53097865 |
| 168 | lipid storage (GO:0019915) | 2.52066754 |
| 169 | endothelium development (GO:0003158) | 2.48717620 |
| 170 | histone arginine methylation (GO:0034969) | 2.48385034 |
| 171 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.48292965 |
| 172 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.47966491 |
| 173 | pentose metabolic process (GO:0019321) | 2.47234130 |
| 174 | mannose metabolic process (GO:0006013) | 2.45525258 |
| 175 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.44551056 |
| 176 | angiogenesis involved in wound healing (GO:0060055) | 2.44217864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.35693786 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.50830220 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.08747261 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.58765119 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.44808248 |
| 6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.31808695 |
| 7 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.31808695 |
| 8 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.31808695 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.29215175 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.15643893 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.12142590 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.77175029 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.75085033 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.61622823 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.57583433 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.53424236 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.45682370 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.35316365 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.24505630 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.14359783 |
| 21 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.13680463 |
| 22 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.13513057 |
| 23 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.01872690 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.95005746 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.88196896 |
| 26 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.87819347 |
| 27 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.83318247 |
| 28 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.74713878 |
| 29 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.73792766 |
| 30 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.67716074 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67678307 |
| 32 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.66767820 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.63929651 |
| 34 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.63907975 |
| 35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.63120697 |
| 36 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.61943170 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.58779641 |
| 38 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.58201762 |
| 39 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.57769168 |
| 40 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.50401521 |
| 41 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.48926720 |
| 42 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47122799 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.45713923 |
| 44 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.44126187 |
| 45 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.43743866 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43693061 |
| 47 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.42162307 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41410379 |
| 49 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.40774162 |
| 50 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.39539232 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38308841 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37304872 |
| 53 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.35039244 |
| 54 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34453214 |
| 55 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.34024928 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.33531473 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.33500136 |
| 58 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.33054732 |
| 59 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.32484115 |
| 60 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.32055251 |
| 61 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.32029129 |
| 62 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31918559 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29371593 |
| 64 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.27065700 |
| 65 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26470787 |
| 66 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.25449154 |
| 67 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23399138 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.22830597 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.21922972 |
| 70 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.21633544 |
| 71 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21108019 |
| 72 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.21080191 |
| 73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21003132 |
| 74 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.19816392 |
| 75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19758162 |
| 76 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.19345171 |
| 77 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19333287 |
| 78 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.19198020 |
| 79 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.18692510 |
| 80 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.18563544 |
| 81 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18443470 |
| 82 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.18304574 |
| 83 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18282406 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17203231 |
| 85 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17149721 |
| 86 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16972503 |
| 87 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.16458143 |
| 88 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.13466839 |
| 89 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.12986172 |
| 90 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12498426 |
| 91 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.11992396 |
| 92 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.11690960 |
| 93 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.11495009 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10928138 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10838691 |
| 96 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10730280 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10249611 |
| 98 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10122985 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09407056 |
| 100 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09347795 |
| 101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08958145 |
| 102 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.08568234 |
| 103 | MAF_26560356_Chip-Seq_TH1_Human | 1.08082671 |
| 104 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07837861 |
| 105 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07607507 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06445925 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06372594 |
| 108 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.05981225 |
| 109 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05965085 |
| 110 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05738492 |
| 111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05442436 |
| 112 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05340585 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05268466 |
| 114 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04846787 |
| 115 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03788693 |
| 116 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03515015 |
| 117 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02752101 |
| 118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02129171 |
| 119 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01641011 |
| 120 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01628717 |
| 121 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.00276529 |
| 122 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00200790 |
| 123 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99698301 |
| 124 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.98739849 |
| 125 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.98704158 |
| 126 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97112290 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96963318 |
| 128 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96647207 |
| 129 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96513080 |
| 130 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.95004150 |
| 131 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.94125660 |
| 132 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.93657723 |
| 133 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93566741 |
| 134 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93174731 |
| 135 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90477635 |
| 136 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90283953 |
| 137 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.88546948 |
| 138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87388712 |
| 139 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.85730548 |
| 140 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.85149577 |
| 141 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.84103378 |
| 142 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.84057817 |
| 143 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83816685 |
| 144 | P68_20966046_ChIP-Seq_HELA_Human | 0.82910070 |
| 145 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.82876017 |
| 146 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82684065 |
| 147 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.82150766 |
| 148 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81836692 |
| 149 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.81493828 |
| 150 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.81059911 |
| 151 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.80504405 |
| 152 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.79347549 |
| 153 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.78996324 |
| 154 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78556224 |
| 155 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.78439494 |
| 156 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77605912 |
| 157 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.77223088 |
| 158 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.77041014 |
| 159 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76854492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.68587319 |
| 2 | MP0005360_urolithiasis | 6.45925231 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.81779941 |
| 4 | MP0005365_abnormal_bile_salt | 4.80094351 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.15411199 |
| 6 | MP0005666_abnormal_adipose_tissue | 4.12879695 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.95198735 |
| 8 | MP0004185_abnormal_adipocyte_glucose | 3.61543906 |
| 9 | MP0005058_abnormal_lysosome_morphology | 3.52899772 |
| 10 | MP0003011_delayed_dark_adaptation | 3.25127966 |
| 11 | MP0003252_abnormal_bile_duct | 2.99212579 |
| 12 | MP0008260_abnormal_autophagy | 2.99017300 |
| 13 | MP0005375_adipose_tissue_phenotype | 2.97103376 |
| 14 | MP0000751_myopathy | 2.88883093 |
| 15 | MP0005332_abnormal_amino_acid | 2.78638083 |
| 16 | MP0004130_abnormal_muscle_cell | 2.58204301 |
| 17 | MP0002254_reproductive_system_inflammat | 2.46889184 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.43304398 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.42871843 |
| 20 | MP0002971_abnormal_brown_adipose | 2.37871002 |
| 21 | MP0009840_abnormal_foam_cell | 2.24331990 |
| 22 | MP0009278_abnormal_bone_marrow | 2.21759443 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.19368045 |
| 24 | MP0002653_abnormal_ependyma_morphology | 2.14704260 |
| 25 | MP0005083_abnormal_biliary_tract | 2.08553464 |
| 26 | MP0000003_abnormal_adipose_tissue | 2.04695323 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 2.01286532 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.96399061 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.93439395 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.88235837 |
| 31 | MP0000609_abnormal_liver_physiology | 1.84987228 |
| 32 | MP0006035_abnormal_mitochondrial_morpho | 1.80793239 |
| 33 | MP0003195_calcinosis | 1.80611724 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.73065922 |
| 35 | MP0003186_abnormal_redox_activity | 1.69275738 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.64227818 |
| 37 | MP0002822_catalepsy | 1.63390069 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.63199743 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.63199743 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.59090783 |
| 41 | MP0006292_abnormal_olfactory_placode | 1.57058541 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.51119779 |
| 43 | MP0001661_extended_life_span | 1.51054920 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.49296617 |
| 45 | MP0004043_abnormal_pH_regulation | 1.48859490 |
| 46 | MP0005535_abnormal_body_temperature | 1.46255229 |
| 47 | MP0009115_abnormal_fat_cell | 1.42641918 |
| 48 | MP0005334_abnormal_fat_pad | 1.40561489 |
| 49 | MP0000343_altered_response_to | 1.37600160 |
| 50 | MP0004957_abnormal_blastocyst_morpholog | 1.36984597 |
| 51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.34645999 |
| 52 | MP0003959_abnormal_lean_body | 1.34314093 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 1.33488390 |
| 54 | MP0000681_abnormal_thyroid_gland | 1.29176138 |
| 55 | MP0005266_abnormal_metabolism | 1.26694277 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.25993420 |
| 57 | MP0000598_abnormal_liver_morphology | 1.25179212 |
| 58 | MP0003890_abnormal_embryonic-extraembry | 1.24322466 |
| 59 | MP0005330_cardiomyopathy | 1.24103028 |
| 60 | MP0003646_muscle_fatigue | 1.23638168 |
| 61 | MP0000858_altered_metastatic_potential | 1.23440256 |
| 62 | MP0003122_maternal_imprinting | 1.21235200 |
| 63 | MP0008438_abnormal_cutaneous_collagen | 1.16733741 |
| 64 | MP0000013_abnormal_adipose_tissue | 1.16383418 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.16173677 |
| 66 | MP0001764_abnormal_homeostasis | 1.15468011 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.14260407 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.12159928 |
| 69 | MP0003279_aneurysm | 1.11617637 |
| 70 | MP0003868_abnormal_feces_composition | 1.09501755 |
| 71 | MP0010030_abnormal_orbit_morphology | 1.08678063 |
| 72 | MP0006138_congestive_heart_failure | 1.07523404 |
| 73 | MP0002933_joint_inflammation | 1.06435080 |
| 74 | MP0008789_abnormal_olfactory_epithelium | 1.05742800 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 1.05675212 |
| 76 | MP0003329_amyloid_beta_deposits | 1.04424969 |
| 77 | MP0003436_decreased_susceptibility_to | 1.02342650 |
| 78 | MP0005452_abnormal_adipose_tissue | 1.02233752 |
| 79 | MP0008057_abnormal_DNA_replication | 1.02066978 |
| 80 | MP0000678_abnormal_parathyroid_gland | 0.98827037 |
| 81 | MP0002396_abnormal_hematopoietic_system | 0.98485078 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.95452480 |
| 83 | MP0005501_abnormal_skin_physiology | 0.93373102 |
| 84 | MP0002876_abnormal_thyroid_physiology | 0.93109337 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.92720145 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.91022866 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.90442694 |
| 88 | MP0004087_abnormal_muscle_fiber | 0.90221520 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.89524387 |
| 90 | MP0005394_taste/olfaction_phenotype | 0.88813106 |
| 91 | MP0005499_abnormal_olfactory_system | 0.88813106 |
| 92 | MP0001881_abnormal_mammary_gland | 0.86779599 |
| 93 | MP0000750_abnormal_muscle_regeneration | 0.85702074 |
| 94 | MP0006082_CNS_inflammation | 0.85550472 |
| 95 | MP0001958_emphysema | 0.84743914 |
| 96 | MP0002132_abnormal_respiratory_system | 0.84136627 |
| 97 | MP0005257_abnormal_intraocular_pressure | 0.83475741 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.80574054 |
| 99 | MP0002092_abnormal_eye_morphology | 0.80487401 |
| 100 | MP0002970_abnormal_white_adipose | 0.79059260 |
| 101 | MP0002088_abnormal_embryonic_growth/wei | 0.78851047 |
| 102 | MP0001672_abnormal_embryogenesis/_devel | 0.78385773 |
| 103 | MP0005380_embryogenesis_phenotype | 0.78385773 |
| 104 | MP0001293_anophthalmia | 0.78256809 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.77946037 |
| 106 | MP0005508_abnormal_skeleton_morphology | 0.77897157 |
| 107 | MP0000749_muscle_degeneration | 0.77753873 |
| 108 | MP0003984_embryonic_growth_retardation | 0.76727492 |
| 109 | MP0005448_abnormal_energy_balance | 0.75610061 |
| 110 | MP0010630_abnormal_cardiac_muscle | 0.74387818 |
| 111 | MP0008469_abnormal_protein_level | 0.74322365 |
| 112 | MP0004858_abnormal_nervous_system | 0.73684678 |
| 113 | MP0000747_muscle_weakness | 0.72893869 |
| 114 | MP0001756_abnormal_urination | 0.72140327 |
| 115 | MP0000537_abnormal_urethra_morphology | 0.72027520 |
| 116 | MP0005451_abnormal_body_composition | 0.71074765 |
| 117 | MP0009763_increased_sensitivity_to | 0.70120903 |
| 118 | MP0004381_abnormal_hair_follicle | 0.69786011 |
| 119 | MP0005385_cardiovascular_system_phenoty | 0.69696467 |
| 120 | MP0001544_abnormal_cardiovascular_syste | 0.69696467 |
| 121 | MP0009379_abnormal_foot_pigmentation | 0.68400662 |
| 122 | MP0003948_abnormal_gas_homeostasis | 0.67729335 |
| 123 | MP0001849_ear_inflammation | 0.67652376 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.67245648 |
| 125 | MP0000249_abnormal_blood_vessel | 0.66883199 |
| 126 | MP0009642_abnormal_blood_homeostasis | 0.65687016 |
| 127 | MP0002269_muscular_atrophy | 0.65686212 |
| 128 | MP0009764_decreased_sensitivity_to | 0.65605326 |
| 129 | MP0004272_abnormal_basement_membrane | 0.64680352 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.64140667 |
| 131 | MP0005647_abnormal_sex_gland | 0.63940886 |
| 132 | MP0000467_abnormal_esophagus_morphology | 0.63741310 |
| 133 | MP0001727_abnormal_embryo_implantation | 0.63458506 |
| 134 | MP0005390_skeleton_phenotype | 0.63330568 |
| 135 | MP0002127_abnormal_cardiovascular_syste | 0.61223431 |
| 136 | MP0002086_abnormal_extraembryonic_tissu | 0.61022847 |
| 137 | MP0005023_abnormal_wound_healing | 0.59984242 |
| 138 | MP0002932_abnormal_joint_morphology | 0.58454372 |
| 139 | MP0000490_abnormal_crypts_of | 0.57523456 |
| 140 | MP0000358_abnormal_cell_content/ | 0.56294136 |
| 141 | MP0003077_abnormal_cell_cycle | 0.55703771 |
| 142 | MP0002928_abnormal_bile_duct | 0.54832563 |
| 143 | MP0002249_abnormal_larynx_morphology | 0.52863183 |
| 144 | MP0003183_abnormal_peptide_metabolism | 0.49960482 |
| 145 | MP0004782_abnormal_surfactant_physiolog | 0.49330634 |
| 146 | MP0005670_abnormal_white_adipose | 0.49130263 |
| 147 | MP0000762_abnormal_tongue_morphology | 0.48752910 |
| 148 | MP0000350_abnormal_cell_proliferation | 0.48212103 |
| 149 | MP0002796_impaired_skin_barrier | 0.48118097 |
| 150 | MP0008872_abnormal_physiological_respon | 0.47861508 |
| 151 | MP0008873_increased_physiological_sensi | 0.47637096 |
| 152 | MP0005220_abnormal_exocrine_pancreas | 0.46682773 |
| 153 | MP0003938_abnormal_ear_development | 0.46532215 |
| 154 | MP0001243_abnormal_dermal_layer | 0.45516386 |
| 155 | MP0000313_abnormal_cell_death | 0.45203683 |
| 156 | MP0001730_embryonic_growth_arrest | 0.43931790 |
| 157 | MP0001765_abnormal_ion_homeostasis | 0.42867179 |
| 158 | MP0002078_abnormal_glucose_homeostasis | 0.42687644 |
| 159 | MP0001853_heart_inflammation | 0.42014271 |
| 160 | MP0002135_abnormal_kidney_morphology | 0.41855921 |
| 161 | MP0000377_abnormal_hair_follicle | 0.41433619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.71756646 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.19210247 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.03083957 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 5.01725064 |
| 5 | Hyperglycinuria (HP:0003108) | 4.58476720 |
| 6 | Multiple enchondromatosis (HP:0005701) | 4.37738247 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.34910726 |
| 8 | Gout (HP:0001997) | 4.33214919 |
| 9 | Xanthomatosis (HP:0000991) | 4.26677145 |
| 10 | Hyperammonemia (HP:0001987) | 4.19460672 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 4.17575631 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.08356755 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.08356755 |
| 14 | Vertebral compression fractures (HP:0002953) | 3.97996259 |
| 15 | Rhabdomyolysis (HP:0003201) | 3.97344112 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.77944508 |
| 17 | Ketosis (HP:0001946) | 3.75637096 |
| 18 | Bilateral microphthalmos (HP:0007633) | 3.71256491 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71156473 |
| 20 | Hepatoblastoma (HP:0002884) | 3.67264135 |
| 21 | Hyperglycinemia (HP:0002154) | 3.59130026 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 3.57048178 |
| 23 | Abnormal cartilage morphology (HP:0002763) | 3.45727002 |
| 24 | Oligomenorrhea (HP:0000876) | 3.43232090 |
| 25 | Ragged-red muscle fibers (HP:0003200) | 3.41356655 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.40436872 |
| 27 | Cerebral palsy (HP:0100021) | 3.36579210 |
| 28 | Malnutrition (HP:0004395) | 3.33354178 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.30441384 |
| 30 | Hypertriglyceridemia (HP:0002155) | 3.29681148 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.29622155 |
| 32 | Increased muscle lipid content (HP:0009058) | 3.26310853 |
| 33 | Cervical subluxation (HP:0003308) | 3.24710857 |
| 34 | Stridor (HP:0010307) | 3.16372916 |
| 35 | Hyperlipoproteinemia (HP:0010980) | 3.10922112 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.10826383 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10088909 |
| 38 | Ketoacidosis (HP:0001993) | 3.07661288 |
| 39 | Protrusio acetabuli (HP:0003179) | 3.06182620 |
| 40 | Growth hormone excess (HP:0000845) | 3.06026781 |
| 41 | Biconcave vertebral bodies (HP:0004586) | 3.03556828 |
| 42 | Exercise-induced myalgia (HP:0003738) | 3.03415904 |
| 43 | Acanthosis nigricans (HP:0000956) | 3.03235660 |
| 44 | Hypolipoproteinemia (HP:0010981) | 3.01250057 |
| 45 | Abnormality of the lower motor neuron (HP:0002366) | 3.01092361 |
| 46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.97106936 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.97106936 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.94914928 |
| 49 | Delayed CNS myelination (HP:0002188) | 2.93050396 |
| 50 | Myoglobinuria (HP:0002913) | 2.91213619 |
| 51 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.90515766 |
| 52 | Hypoglycemic coma (HP:0001325) | 2.89378156 |
| 53 | Dysostosis multiplex (HP:0000943) | 2.87992851 |
| 54 | Microvesicular hepatic steatosis (HP:0001414) | 2.86281161 |
| 55 | Reduced antithrombin III activity (HP:0001976) | 2.86256802 |
| 56 | Joint hemorrhage (HP:0005261) | 2.85927461 |
| 57 | Joint stiffness (HP:0001387) | 2.82957878 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.81191640 |
| 59 | Abnormality of methionine metabolism (HP:0010901) | 2.80682666 |
| 60 | Metabolic acidosis (HP:0001942) | 2.75997187 |
| 61 | Cholecystitis (HP:0001082) | 2.74689939 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.74689939 |
| 63 | Increased purine levels (HP:0004368) | 2.73828609 |
| 64 | Hyperuricemia (HP:0002149) | 2.73828609 |
| 65 | Muscle stiffness (HP:0003552) | 2.71813888 |
| 66 | Mucopolysacchariduria (HP:0008155) | 2.69356637 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69356637 |
| 68 | Lymphangioma (HP:0100764) | 2.65525804 |
| 69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.63996870 |
| 70 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.63996870 |
| 71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.63996870 |
| 72 | Fat malabsorption (HP:0002630) | 2.62945366 |
| 73 | Complement deficiency (HP:0004431) | 2.62429889 |
| 74 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.61371455 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.61092834 |
| 76 | Hyperbilirubinemia (HP:0002904) | 2.59851057 |
| 77 | Skin nodule (HP:0200036) | 2.58579196 |
| 78 | Increased variability in muscle fiber diameter (HP:0003557) | 2.55405933 |
| 79 | Hypoalphalipoproteinemia (HP:0003233) | 2.53874429 |
| 80 | J-shaped sella turcica (HP:0002680) | 2.52918494 |
| 81 | Rhabdomyosarcoma (HP:0002859) | 2.51387240 |
| 82 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.50469231 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.49566999 |
| 84 | Hypochromic anemia (HP:0001931) | 2.46861321 |
| 85 | Myopathic facies (HP:0002058) | 2.45844496 |
| 86 | Lethargy (HP:0001254) | 2.45606983 |
| 87 | Increased connective tissue (HP:0009025) | 2.44291598 |
| 88 | Spastic diplegia (HP:0001264) | 2.43662361 |
| 89 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.42838654 |
| 90 | Progressive muscle weakness (HP:0003323) | 2.40362490 |
| 91 | Hypercholesterolemia (HP:0003124) | 2.39941792 |
| 92 | Abnormality of the common coagulation pathway (HP:0010990) | 2.39523870 |
| 93 | Epidermoid cyst (HP:0200040) | 2.35816716 |
| 94 | Systemic lupus erythematosus (HP:0002725) | 2.35295929 |
| 95 | Abnormality of serum amino acid levels (HP:0003112) | 2.35163413 |
| 96 | Distal lower limb muscle weakness (HP:0009053) | 2.33711311 |
| 97 | Neoplasm of striated muscle (HP:0009728) | 2.33669675 |
| 98 | Vomiting (HP:0002013) | 2.32824354 |
| 99 | Irritability (HP:0000737) | 2.32115817 |
| 100 | Broad distal phalanx of finger (HP:0009836) | 2.30960930 |
| 101 | Hepatocellular necrosis (HP:0001404) | 2.29599282 |
| 102 | Hepatosplenomegaly (HP:0001433) | 2.28471728 |
| 103 | Back pain (HP:0003418) | 2.28319240 |
| 104 | Hemorrhage of the eye (HP:0011885) | 2.27648240 |
| 105 | Partial duplication of thumb phalanx (HP:0009944) | 2.23477328 |
| 106 | Hepatocellular carcinoma (HP:0001402) | 2.20383873 |
| 107 | Hepatic necrosis (HP:0002605) | 2.20128685 |
| 108 | Colitis (HP:0002583) | 2.18049212 |
| 109 | Ependymoma (HP:0002888) | 2.17126429 |
| 110 | Easy fatigability (HP:0003388) | 2.13691248 |
| 111 | Abnormality of complement system (HP:0005339) | 2.13555750 |
| 112 | Rib fusion (HP:0000902) | 2.11951211 |
| 113 | Gastrointestinal dysmotility (HP:0002579) | 2.11932372 |
| 114 | Abnormality of the Achilles tendon (HP:0005109) | 2.08835035 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.07635350 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 2.07605602 |
| 117 | Reticulocytosis (HP:0001923) | 2.07128168 |
| 118 | Type I transferrin isoform profile (HP:0003642) | 2.05735696 |
| 119 | Hypertensive crisis (HP:0100735) | 2.04799629 |
| 120 | Testicular atrophy (HP:0000029) | 2.04311515 |
| 121 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.04242712 |
| 122 | Enlarged kidneys (HP:0000105) | 2.02902543 |
| 123 | Distal lower limb amyotrophy (HP:0008944) | 2.00048790 |
| 124 | Thoracic kyphosis (HP:0002942) | 1.99977315 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.99395130 |
| 126 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98955694 |
| 127 | 3-Methylglutaconic aciduria (HP:0003535) | 1.98124086 |
| 128 | Insulin resistance (HP:0000855) | 1.97514358 |
| 129 | Increased serum ferritin (HP:0003281) | 1.96559559 |
| 130 | Difficulty climbing stairs (HP:0003551) | 1.96391354 |
| 131 | Partial duplication of the phalanx of hand (HP:0009999) | 1.93016323 |
| 132 | Agammaglobulinemia (HP:0004432) | 1.92578953 |
| 133 | Late onset (HP:0003584) | 1.92007300 |
| 134 | Abnormality of glycolysis (HP:0004366) | 1.91981607 |
| 135 | Increased serum pyruvate (HP:0003542) | 1.91981607 |
| 136 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91391901 |
| 137 | Prolonged neonatal jaundice (HP:0006579) | 1.90975926 |
| 138 | Neck muscle weakness (HP:0000467) | 1.89309969 |
| 139 | Opisthotonus (HP:0002179) | 1.88929719 |
| 140 | Steatorrhea (HP:0002570) | 1.87983942 |
| 141 | Rickets (HP:0002748) | 1.87283965 |
| 142 | Seborrheic dermatitis (HP:0001051) | 1.87213184 |
| 143 | Bile duct proliferation (HP:0001408) | 1.86882867 |
| 144 | Abnormal biliary tract physiology (HP:0012439) | 1.86882867 |
| 145 | Alkalosis (HP:0001948) | 1.84538965 |
| 146 | Pseudobulbar signs (HP:0002200) | 1.84306833 |
| 147 | Abnormality of the thoracic spine (HP:0100711) | 1.83809813 |
| 148 | Microretrognathia (HP:0000308) | 1.83713656 |
| 149 | Vaginal fistula (HP:0004320) | 1.83275813 |
| 150 | Glycosuria (HP:0003076) | 1.82784541 |
| 151 | Abnormality of urine glucose concentration (HP:0011016) | 1.82784541 |
| 152 | Cholelithiasis (HP:0001081) | 1.82197367 |
| 153 | Neonatal onset (HP:0003623) | 1.82110397 |
| 154 | Short nail (HP:0001799) | 1.81793735 |
| 155 | Interstitial pulmonary disease (HP:0006530) | 1.80093467 |
| 156 | Tetraplegia (HP:0002445) | 1.79527510 |
| 157 | Cellulitis (HP:0100658) | 1.79386435 |
| 158 | Spinal rigidity (HP:0003306) | 1.78949495 |
| 159 | Atelectasis (HP:0100750) | 1.78634624 |
| 160 | Nuclear cataract (HP:0100018) | 1.77961089 |
| 161 | Conjugated hyperbilirubinemia (HP:0002908) | 1.76011773 |
| 162 | Nausea (HP:0002018) | 1.75650234 |
| 163 | Premature rupture of membranes (HP:0001788) | 1.75136326 |
| 164 | Polygenic inheritance (HP:0010982) | 1.75033752 |
| 165 | Distal upper limb amyotrophy (HP:0007149) | 1.73825149 |
| 166 | Upper limb amyotrophy (HP:0009129) | 1.73825149 |
| 167 | Abnormality of the salivary glands (HP:0010286) | 1.73582051 |
| 168 | Mesangial abnormality (HP:0001966) | 1.73331043 |
| 169 | Exercise intolerance (HP:0003546) | 1.71855314 |
| 170 | Elevated alkaline phosphatase (HP:0003155) | 1.71265655 |
| 171 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.70691134 |
| 172 | Bulbar palsy (HP:0001283) | 1.69579328 |
| 173 | Spastic paraparesis (HP:0002313) | 1.67187514 |
| 174 | Abnormality of glycolipid metabolism (HP:0010969) | 1.66553449 |
| 175 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.66553449 |
| 176 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.66553449 |
| 177 | Progressive neurologic deterioration (HP:0002344) | 1.65184503 |
| 178 | Achilles tendon contracture (HP:0001771) | 1.64720243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.62103367 |
| 2 | CDK12 | 5.59717817 |
| 3 | BCKDK | 4.28172388 |
| 4 | GRK6 | 4.16173106 |
| 5 | GRK5 | 3.31633577 |
| 6 | TESK1 | 3.02622399 |
| 7 | CSF1R | 2.79084083 |
| 8 | PIM2 | 2.67027771 |
| 9 | VRK2 | 2.55239543 |
| 10 | TGFBR2 | 2.54499363 |
| 11 | GRK1 | 2.50753286 |
| 12 | TESK2 | 2.44351721 |
| 13 | ARAF | 2.17655295 |
| 14 | ADRBK2 | 2.16684302 |
| 15 | TTK | 2.08813202 |
| 16 | MAP3K10 | 1.97847690 |
| 17 | FLT3 | 1.96769339 |
| 18 | BUB1 | 1.90222560 |
| 19 | STK10 | 1.86759254 |
| 20 | MATK | 1.82314621 |
| 21 | SMG1 | 1.79112938 |
| 22 | SIK1 | 1.72806243 |
| 23 | TBK1 | 1.69284011 |
| 24 | MAPK7 | 1.63254243 |
| 25 | NME2 | 1.61876983 |
| 26 | CDK7 | 1.51172658 |
| 27 | PAK4 | 1.43724135 |
| 28 | PRPF4B | 1.40815957 |
| 29 | MAP2K6 | 1.37781748 |
| 30 | SCYL2 | 1.37261074 |
| 31 | MOS | 1.34040500 |
| 32 | GRK7 | 1.31485840 |
| 33 | TYRO3 | 1.31102765 |
| 34 | EPHB2 | 1.30698949 |
| 35 | PRKG2 | 1.30341574 |
| 36 | MAP2K3 | 1.28864953 |
| 37 | FGFR4 | 1.27855557 |
| 38 | MAP2K4 | 1.27008463 |
| 39 | PKN2 | 1.24782456 |
| 40 | CDK19 | 1.22736880 |
| 41 | MAP3K7 | 1.21204867 |
| 42 | PRKD2 | 1.20515609 |
| 43 | NEK1 | 1.17523067 |
| 44 | CAMK4 | 1.09949619 |
| 45 | WNK3 | 1.05816365 |
| 46 | EPHA2 | 1.04241854 |
| 47 | WEE1 | 1.04201092 |
| 48 | TRIB3 | 1.03361820 |
| 49 | TNK2 | 1.00801818 |
| 50 | WNK1 | 1.00127530 |
| 51 | EPHB1 | 0.98755873 |
| 52 | FGFR3 | 0.98295606 |
| 53 | ACVR1B | 0.97671602 |
| 54 | DAPK1 | 0.97235642 |
| 55 | TIE1 | 0.96494651 |
| 56 | MAP3K13 | 0.95695626 |
| 57 | CDK4 | 0.93136001 |
| 58 | ICK | 0.92587262 |
| 59 | NEK2 | 0.89474058 |
| 60 | LIMK1 | 0.89361521 |
| 61 | TTN | 0.85525654 |
| 62 | MAP3K6 | 0.83824480 |
| 63 | PLK1 | 0.83798514 |
| 64 | PTK6 | 0.83525173 |
| 65 | RIPK1 | 0.80271677 |
| 66 | BMX | 0.78986978 |
| 67 | FES | 0.76816701 |
| 68 | MAPK11 | 0.76349519 |
| 69 | AKT2 | 0.76181159 |
| 70 | JAK3 | 0.74888455 |
| 71 | DDR2 | 0.73525433 |
| 72 | KDR | 0.72998595 |
| 73 | RPS6KB2 | 0.72482884 |
| 74 | MAPK12 | 0.71589211 |
| 75 | CSK | 0.71458774 |
| 76 | IRAK3 | 0.69871175 |
| 77 | MAP4K2 | 0.69092295 |
| 78 | DYRK3 | 0.68447324 |
| 79 | MAP4K1 | 0.68051936 |
| 80 | ADRBK1 | 0.66383117 |
| 81 | PDGFRA | 0.65905385 |
| 82 | DAPK3 | 0.65873739 |
| 83 | PRKD3 | 0.65235122 |
| 84 | CHEK2 | 0.65157078 |
| 85 | KIT | 0.63494876 |
| 86 | MYLK | 0.61856032 |
| 87 | BTK | 0.61115914 |
| 88 | RPS6KL1 | 0.60861648 |
| 89 | RPS6KC1 | 0.60861648 |
| 90 | TGFBR1 | 0.60531281 |
| 91 | WNK4 | 0.60446863 |
| 92 | MAPKAPK3 | 0.60111441 |
| 93 | RPS6KA2 | 0.59787228 |
| 94 | DYRK1B | 0.59373948 |
| 95 | MTOR | 0.59176181 |
| 96 | CDK9 | 0.58949515 |
| 97 | PDPK1 | 0.57614488 |
| 98 | LRRK2 | 0.55563228 |
| 99 | MAP3K3 | 0.55209562 |
| 100 | ILK | 0.54505730 |
| 101 | MAPK4 | 0.54495775 |
| 102 | MAP2K2 | 0.52330564 |
| 103 | ZAP70 | 0.50328775 |
| 104 | AURKB | 0.48532716 |
| 105 | MARK2 | 0.48223795 |
| 106 | ERBB2 | 0.48047054 |
| 107 | HIPK2 | 0.47764013 |
| 108 | PRKAA2 | 0.46404780 |
| 109 | NTRK1 | 0.45867533 |
| 110 | MAP3K11 | 0.45261660 |
| 111 | TAOK2 | 0.44706281 |
| 112 | PRKD1 | 0.44456897 |
| 113 | MAP3K1 | 0.44316198 |
| 114 | ABL2 | 0.43068444 |
| 115 | PTK2 | 0.42188155 |
| 116 | TYK2 | 0.41966211 |
| 117 | PAK1 | 0.40357743 |
| 118 | ERBB4 | 0.40184772 |
| 119 | STK16 | 0.39774454 |
| 120 | AURKA | 0.39638489 |
| 121 | EEF2K | 0.39631909 |
| 122 | RPS6KA6 | 0.39587595 |
| 123 | PDK4 | 0.39322447 |
| 124 | PDK3 | 0.39322447 |
| 125 | CHEK1 | 0.38919599 |
| 126 | BRAF | 0.38559008 |
| 127 | RAF1 | 0.38421912 |
| 128 | MAP3K8 | 0.38362209 |
| 129 | NME1 | 0.37970459 |
| 130 | CSNK1G3 | 0.36974142 |
| 131 | PRKCI | 0.36746847 |
| 132 | ITK | 0.36422256 |
| 133 | JAK2 | 0.35735937 |
| 134 | BLK | 0.35401130 |
| 135 | IGF1R | 0.35274767 |
| 136 | CAMK2G | 0.35247341 |
| 137 | MAPK15 | 0.35003697 |
| 138 | SRC | 0.34901910 |
| 139 | IKBKB | 0.34655893 |
| 140 | MAPK3 | 0.33187295 |
| 141 | MUSK | 0.32872510 |
| 142 | CDK8 | 0.32500609 |
| 143 | RPS6KA4 | 0.32036208 |
| 144 | PRKACG | 0.31879373 |
| 145 | MST1R | 0.31314870 |
| 146 | STK4 | 0.30573418 |
| 147 | GSK3A | 0.29944493 |
| 148 | PIM1 | 0.28430846 |
| 149 | OXSR1 | 0.28358977 |
| 150 | AKT3 | 0.27267556 |
| 151 | EIF2AK2 | 0.26178829 |
| 152 | PRKCD | 0.26128277 |
| 153 | PRKAA1 | 0.25119734 |
| 154 | STK38L | 0.24550553 |
| 155 | CDK2 | 0.24337828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.48571559 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20711069 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.88672153 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62259581 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.62217583 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.61935058 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61773801 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50732210 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.35322043 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.33044532 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.32875105 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31755331 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.29386576 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.02908805 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.99372634 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98553122 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97392111 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.95216186 |
| 19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.87480605 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85934419 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.85595007 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80781050 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80267789 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.79119605 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.76198006 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.55968756 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55801864 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55225194 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54367932 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54253405 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.53637864 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.52678407 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52058266 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.51349120 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.51280091 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47977984 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47225032 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46538751 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44925242 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44626101 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.44325130 |
| 42 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.44188998 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28829379 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.23963224 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.22261140 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21961522 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.20157016 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14051899 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12850485 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11477159 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10698315 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07886598 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06241318 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03098250 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.02796918 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02108956 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99982106 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98675863 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98365617 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90699953 |
| 61 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.88021418 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87935917 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.84892276 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83687788 |
| 65 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.83600178 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.83340150 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80953583 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80153898 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79587100 |
| 70 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79397895 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79197318 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77790243 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.74552239 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70920557 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67485602 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65960287 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65773377 |
| 78 | DNA replication_Homo sapiens_hsa03030 | 0.65104747 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.63888392 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63833817 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63021679 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60801263 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60111927 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57405879 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49931968 |
| 86 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.43961482 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41091241 |
| 88 | Mismatch repair_Homo sapiens_hsa03430 | 0.34690217 |
| 89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34467098 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33548475 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31530963 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.29173441 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28933190 |
| 94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.26807217 |
| 95 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.26724480 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.26435984 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23093405 |
| 98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22451971 |
| 99 | Base excision repair_Homo sapiens_hsa03410 | 0.22410642 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.21828759 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.19570217 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.18990908 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18636564 |
| 104 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.18634193 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17899687 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17757582 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17693953 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17646014 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17212695 |
| 110 | RNA transport_Homo sapiens_hsa03013 | 0.15468820 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14803143 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.14578913 |
| 113 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.14399101 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13801173 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.11993954 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.11799594 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.11684926 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11472731 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.09233025 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.08875611 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08502086 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07207679 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05322062 |
| 124 | Homologous recombination_Homo sapiens_hsa03440 | 0.02898716 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0464854 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0429268 |
| 127 | Spliceosome_Homo sapiens_hsa03040 | -0.0348578 |
| 128 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0302410 |

